
“…each day that passes is a lost day of peak sales…”
The new chairman of the Danish biotech company Forward Pharma, CEO Florian Schönharting of Nordic Biotech/NB Capital - which owns the company along with Rosetta Capital – makes no bones about his intentions to use his new influence as chairman. Schönharting has taken over the reins from Wyle David Solomon in 2012.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app